Cyclacel Pharmaceuticals, Inc.·4

May 24, 7:19 PM ET

Rombotis Spiro George 4

4 · Cyclacel Pharmaceuticals, Inc. · Filed May 24, 2013

Insider Transaction Report

Form 4
Period: 2013-05-21
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
  • Purchase

    Common Stock, $0.001 par value per share

    2013-05-21$3.00/sh+100,000$300,000241,416 total
Footnotes (1)
  • [F1]Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account and 30,714 shares are represented by unvested restricted stock units.

Documents

1 file
  • 4
    a4.xmlPrimary

    4